Drugs / Artemisinin
Artemisinin
also known as
Artemisinina · Artemisinine · Artemisininum · GNF-PF-5341 · Huanghuahaosu · NSC-369397 · Qing hau sau
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01391403 | Sep 2008 → Apr 2011 | schizophrenia | Beijing HuiLongGuan Hospital | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT05004753 | Sep 2020 → Feb 2021 | COVID-19 | Mateon Therapeutics | Completed | No outcome recorded |
| Phase 4 | NCT01930331 | Jan → Jul 2014 | Plasmodium falciparum malaria | Ifakara Health Institute | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04801017 Background | Apr → Aug 2021 | COVID-19 | Oncotelic Inc. | Unknown | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | artemisinin | “Subject's compliance with the study treatment regimen of Artemisinin one (1) capsule a day for five (5) days, will be assessed during treatment period.” NCT05004753 ↗ |
| Known as | Artemisinina | ChEMBL registry synonym — accepted as the source's own label CHEMBL269671 ↗ |
| Known as | Artemisinine | ChEMBL registry synonym — accepted as the source's own label CHEMBL269671 ↗ |
| Known as | Artemisininum | ChEMBL registry synonym — accepted as the source's own label CHEMBL269671 ↗ |
| Known as | GNF-PF-5341 | ChEMBL registry synonym — accepted as the source's own label CHEMBL269671 ↗ |
| Known as | Huanghuahaosu | ChEMBL registry synonym — accepted as the source's own label CHEMBL269671 ↗ |
| Known as | NSC-369397 | ChEMBL registry synonym — accepted as the source's own label CHEMBL269671 ↗ |
| Known as | Qing hau sau | ChEMBL registry synonym — accepted as the source's own label CHEMBL269671 ↗ |
| Modality | Small molecule | — CHEMBL269671 ↗ |
| Route | Oral | “500 mg per day for 5 days by oral” NCT04801017 ↗ |